Global Cell and Gene Therapy Bioassay Services Market Size is estimated to grow at a 25.0% CAGR during the forecast period for 2025-2034.
Cell and gene therapy focuses on modifying genetic material to improve functioning or treat a disease. These advanced therapies are one of the highest valued therapeutic segments within the biopharmaceutical industry and can address the most challenging diseases. Bioassay services play a critical role in the cell and gene therapy development process.
The key factors driving the growth of the cell and gene therapy bioassay services market include the high prevalence of chronic diseases and genetic disorders, the rising elderly population, the growing preference of patients toward personalized treatments, and increased technological advancements. Considering the demand for bioassays and the competitiveness of the biologics industry, many drug developers prefer outsourcing bioanalytical services that offer bioassay services for quick and efficient therapy analysis and development. Likely to compel the growth opportunities for the cell and gene therapy bioassay services market in the coming years.
However, the expensive bioassay services offered by the contract research organizations (CROs) may hinder the market growth over the forecast period.
The cell and gene therapy bioassay services market are classified based on the type of therapy, therapeutic area, scale of operation, and region. By type of therapy, the market comprises cell therapy and gene therapy. The cell therapy segment is expected to hold the maximum market share in the coming days owing to the rising demand and awareness regarding cell therapies. The market is classified into oncological, infectious, autoimmune, rare/ genetic, cardiovascular, metabolic, blood, neurological, ophthalmic disorders, and other therapeutic areas in terms of therapeutic area. The oncological segment is expected to be the fastest-growing segment of this market in the coming years, owing to the high prevalence of cancer and the rising aging population. The scale of operation segment is grouped into discovery, preclinical, and clinical. Regionally, the market is studied across North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. North America is projected to dominate this market over the forecast period, followed by Europe and Asia-Pacific.
| Report Attribute | Specifications |
| Market Size Value In 2024 | USD XX Billion |
| Revenue Forecast In 2034 | USD XX Billion |
| Growth Rate CAGR | CAGR of 25.0% from 2025 to 2034 |
| Quantitative Units | Representation of revenue in US$ Bn and CAGR from 2025 to 2034 |
| Historic Year | 2021 to 2024 |
| Forecast Year | 2025-2034 |
| Report Coverage | The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
| Segments Covered | By Type of Therapy, By Therapeutic Area, By Scale of Operation |
| Regional Scope | North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
| Country Scope | U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico ;The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia |
| Competitive Landscape | AnaBioTec (Belgium), CCRM (Canada), Nexelis (Canada), Pacific BioLabs (US), PPD Laboratories (North Carolina), Intertek Pharmaceutical Services (UK), Lonza (Switzerland), Porton Biopharma Ltd (UK), WuXi Advanced Therapies (US), Avomeen (US), Charles River Laboratories (US), Absorption Systems (US), BioAgilytix Labs (US), Catalent, Inc (US), Svar Life Science AB (Sweden), and others. |
| Customization Scope | Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
| Pricing And Available Payment Methods | Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Cell and Gene Therapy Bioassay Services Market Snapshot
Chapter 4. Global Cell and Gene Therapy Bioassay Services Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 2: By Therapeutic Area Estimates & Trend Analysis
5.1. By Therapeutic Area & Market Share, 2024 & 2034
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Therapeutic Area:
5.2.1. Oncological
5.2.2. Infectious
5.2.3. Autoimmune
5.2.4. Rare / Genetic
5.2.5. Cardiovascular
5.2.6. Metabolic
5.2.7. Blood
5.2.8. Neurological
5.2.9. Ophthalmic Disorders
5.2.10. Other Therapeutic Areas
Chapter 6. Market Segmentation 3: By Therapy Estimates & Trend Analysis
6.1. By Therapy & Market Share, 2024 & 2034
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Therapy:
6.2.1. Cell Therapy
6.2.2. Gene Therapy
Chapter 7. Market Segmentation 4: By Scale of Operations Estimates & Trend Analysis
7.1. By Scale of Operations & Market Share, 2024 & 2034
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Scale of Operations:
7.2.1. Discovery
7.2.2. Preclinical
7.2.3. Clinical
Chapter 8. Cell and Gene Therapy Bioassay Services Market Segmentation 5: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America Cell and Gene Therapy Bioassay Services Market revenue (US$ Million) estimates and forecasts By Therapeutic Area, 2021-2034
8.1.2. North America Cell and Gene Therapy Bioassay Services Market revenue (US$ Million) estimates and forecasts By Therapy, 2021-2034
8.1.3. North America Cell and Gene Therapy Bioassay Services Market revenue (US$ Million) estimates and forecasts by Scale of Operations, 2021-2034
8.1.4. North America Cell and Gene Therapy Bioassay Services Market revenue (US$ Million) estimates and forecasts by country, 2021-2034
8.2. Europe
8.2.1. Europe Cell and Gene Therapy Bioassay Services Market revenue (US$ Million) By Therapeutic Area, 2021-2034
8.2.2. Europe Cell and Gene Therapy Bioassay Services Market revenue (US$ Million) By Therapy, 2021-2034
8.2.3. Europe Cell and Gene Therapy Bioassay Services Market revenue (US$ Million) estimates and forecasts by Scale of Operations, 2021-2034
8.2.4. Europe Cell and Gene Therapy Bioassay Services Market revenue (US$ Million) by country, 2021-2034
8.3. Asia Pacific
8.3.1. Asia Pacific Cell and Gene Therapy Bioassay Services Market revenue (US$ Million) By Therapeutic Area, 2021-2034
8.3.2. Asia Pacific Cell and Gene Therapy Bioassay Services Market revenue (US$ Million) By Therapy, 2021-2034
8.3.3. Asia Pacific Cell and Gene Therapy Bioassay Services Market revenue (US$ Million) estimates and forecasts by Scale of Operations, 2021-2034
8.3.4. Asia Pacific Cell and Gene Therapy Bioassay Services Market revenue (US$ Million) by country, 2021-2034
8.4. Latin America
8.4.1. Latin America Cell and Gene Therapy Bioassay Services Market revenue (US$ Million) By Therapeutic Area, 2021-2034
8.4.2. Latin America Cell and Gene Therapy Bioassay Services Market revenue (US$ Million) By Therapy, 2021-2034
8.4.3. Latin America Cell and Gene Therapy Bioassay Services Market revenue (US$ Million) estimates and forecasts by Scale of Operations, 2021-2034
8.4.4. Latin America Cell and Gene Therapy Bioassay Services Market revenue (US$ Million) by country, 2021-2034
8.5. Middle East & Africa
8.5.1. Middle East & Africa Cell and Gene Therapy Bioassay Services Market revenue (US$ Million) By Therapeutic Area, 2021-2034
8.5.2. Middle East & Africa Cell and Gene Therapy Bioassay Services Market revenue (US$ Million) By Therapy, 2021-2034
8.5.3. Middle East & Africa Cell and Gene Therapy Bioassay Services Market revenue (US$ Million) estimates and forecasts by Scale of Operations, 2021-2034
8.5.4. Middle East & Africa Cell and Gene Therapy Bioassay Services Market revenue (US$ Million) by country, 2021-2034
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. AnaBioTec
9.2.2. CCRM
9.2.3. Nexelis
9.2.4. Pacific BioLabs
9.2.5. PPD Laboratories
9.2.6. Intertek Pharmaceutical Services
9.2.7. Lonza
9.2.8. Porton Bio
9.2.9. WuXi Advanced Therapies
9.2.10. Avomeen
9.2.11. Charles River Laboratories
9.2.12. Absorption Systems
9.2.13. BioAgilytix Labs
9.2.14. Catalent, Inc
9.2.15. MilliporeSigma
9.2.16. Svar Life Science AB
Other Prominent Players
Global Cell and Gene Therapy Bioassay Services Market, by Type of Therapy
Global Cell and Gene Therapy Bioassay Services Market, by Therapeutic Area
Global Cell and Gene Therapy Bioassay Services Market, by Scale of Operation
Global Cell and Gene Therapy Bioassay Services Market, by Region
North America Cell and Gene Therapy Bioassay Services Market, by Country
Europe Cell and Gene Therapy Bioassay Services Market, by Country
Asia Pacific Cell and Gene Therapy Bioassay Services Market, by Country
Latin America Cell and Gene Therapy Bioassay Services Market, by Country
Middle East & Africa Cell and Gene Therapy Bioassay Services Market, by Country
Competitive Landscape
Latest Strategic Developments